Thus, combination treatment of tamoxifen and CSC 3436 produced stronger tumor growth inhibition in comparison to the CSC 3436 or tamoxifen alone treatments tamoxifen endometrial cancer preferably 3 4 weeks prior to the administration of the cellular immunotherapies